pH-responsive polymersome-mediated delivery of doxorubicin into tumor sites enhances the therapeutic efficacy and reduces cardiotoxic effects

CALUMBY ALBUQUERQUE, L. J., SINCARI, V., JÄGER, A., KUČKA, J., HUMAJOVÁ, J., PANKRÁC, J., PÁRAL, P., HEIZER, T., JANOUŠKOVÁ, O., DAVIDOVICH, I., TALMON, Y., POUCKOVA, P., ŠTĚPÁNEK, P., ŠEFC, L., HRUBÝ, M., GIACOMELLI, F. C., JÄGER, E. pH-responsive polymersome-mediated delivery of doxorubicin into tumor sites enhances the therapeutic efficacy and reduces cardiotoxic effects. Journal of Controlled Release. 2021, 332(10 April), 529-538. ISSN 0168-3659. E-ISSN 1873-4995. Available: doi: 10.1016/j.jconrel.2021.03.013.